[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT00628199":3,"trial-entities:NCT00628199":62,"trial-summary:NCT00628199":70},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":21,"study_type":22,"primary_purpose":15,"phases":23,"enrollment_info":24,"interventions":27,"primary_outcomes":31,"secondary_outcomes":32,"sex":33,"minimum_age":34,"maximum_age":35,"healthy_volunteers":36,"eligibility_criteria":37,"std_ages":41,"locations":45,"central_contacts":55,"overall_officials":56,"references":60,"see_also_links":61},"NCT00628199","SU-12202007-950","Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability","Derivation of Primary Donor Cell Lines for Human Cell Reprogramming","ENROLLING_BY_INVITATION","2030-01","2022-08","2022-08-12","2007-09","Stanford University","OTHER",null,"This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and\u002For genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.","It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.",[19,20],"Metabolic Diseases","Infertility",[],"OBSERVATIONAL",[],{"count":25,"type":26},60,"ESTIMATED",[28],{"type":29,"name":30},"PROCEDURE","Improving the scientific process of human cell reprogramming",[],[],"ALL","1 Year","75 Years",true,{"inclusion":38,"exclusion":39,"raw_text":40},[],[],"Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)\n\nExclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.",[42,43,44],"CHILD","ADULT","OLDER_ADULT",[46],{"facility":47,"city":48,"state":49,"zip":50,"country":51,"geoPoint":52},"Stanford University School of Medicine","Stanford","California","94305","United States",{"lat":53,"lon":54},37.42411,-122.16608,[],[57],{"name":58,"affiliation":13,"role":59},"Marius Wernig, MD","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":63,"biomarkers":69},[64,65,20,66,67,68],"Azoospermia","Heart Disorder","Metabolic Disorder","Premature Menopause","Type 1 Diabetes Mellitus",[],{"nct_id":4,"found":71,"summary":15,"prompt_version":15},false]